The new device could help researchers see how different types of tissue respond to drugs without using lab animals.
Back story: Current organ-on-a chip systems place different kinds of human cells into a device andthen push fluid through them to mimic blood flow. That lets researchers see how, say, lung cells respond to different conditions.
What’s new: MIT engineers have now built a more complex version, which combines cells from 10 different organs—liver, lung, gut, endometrium, brain, heart, pancreas, kidney, skin, and skeletal muscle. That allows tests to see how different model organs react and interact with each other when exposed to different chemicals in the fluid.
Why it matters: The cells can live for up to four weeks of testing, and the team has already used the setup to see how the different model organs respond to painkillers. It’s still a crude approximation of our body, but it could be used to test how organs react to early-stage drugs.
Biotechnology and health
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
A biotech company says it put dopamine-making cells into people’s brains
The experiment to treat Parkinson’s is a critical early test of stem cells’ potential to tackle serious disease.
Tiny faux organs could crack the mystery of menstruation
Researchers are using organoids to unlock one of the human body’s most mysterious—and miraculous—processes.
After 25 years of hype, embryonic stem cells are still waiting for their moment
Research roadblocks and political debates have delayed progress—but scientists are inching closer to delivering a cure.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.